The results of aflibercept therapy as a first line treatment of age-related macular degeneration
Journal of Current Ophthalmology, 2019 Purpose: To report the results of aflibercept treatment in treatment-naive neovascular age-related macular degeneration (AMD) patients and suggest a suitable treatment algorithm for routine clinical practice.
Erkan Unsal, Mehmet Ozgur Cubuk
doaj +1 more source
The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited [PDF]
, 2017 BACKGROUND: To compare a near decade of follow-up, newer control cohort data, use of both the societal and third party insurer cost perspectives, and integration of unilateral/bilateral therapy on the comparative effectiveness and cost-effectiveness of ...
Adam Turpcu +4 more
core +1 more source
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration
Journal of Ophthalmology, 2015 Herein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD). Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes.
Eui Chun Kang, Hyoung Jun Koh
doaj +1 more source
Acta Ophthalmologica, Volume 104, Issue 3, Page e277-e291, May 2026.Abstract Purpose The retinal pigment epithelium (RPE) is critical in the pathophysiology of retinal diseases, such as age‐related macular degeneration. Adaptive optics transscleral flood illumination (AO‐TFI) offers rapid, detailed morphometric characterization of the RPE layer.
Leila Sara Eppenberger +8 more
wiley +1 more source
Therapeutic Gases in Biomedicine: Updates on Nitric Oxide and Beyond
Advanced Science, Volume 13, Issue 23, 23 April 2026.Therapeutic gases, including NO, CO, H2S, H2, CO2, O2, and Xe, play vital roles in cellular signaling and repair. This review highlights the emerging carriers and delivery systems that enable controlled, localized gas release for diagnostic and therapeutic applications.
Syed Muntazir Andrabi +4 more
wiley +1 more source
Intravitreal bevacizumab for neovascular age-related macular degeneration
Philippine Journal of Ophthalmology, 2009 Objectives: Anti-vascular endothelial growth factor (anti-VEGF) drugs delivered intravitreally have been proven effective and safe for the treatment of patients diagnosed with neovascular age-related macular degeneration (ARMD).
Junn R. Pajarillo, MD +2 more
doaj
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment : evidence from the RESTORE trial [PDF]
, 2012 Background/aims To evaluate the cost-effectiveness of ranibizumab as either monotherapy or combined with laser therapy, compared with laser monotherapy, in the treatment of diabetic macular oedema (DME) causing visual impairment from a UK healthcare ...
Mitchell, Paul +7 more
core +2 more sources
Circulating angiogenesis‐related biomarkers in sickle cell retinopathy and maculopathy
British Journal of Haematology, Volume 208, Issue 4, Page 1398-1406, April 2026.Summary Sickle cell disease (SCD), encompassing genotypes such as HbSS and HbSC, leads to retinal complications such as sickle cell retinopathy (SCR) and maculopathy (SCM) through poorly understood mechanisms. This study explored associations of a panel of circulating angiogenesis‐related factors with SCR and SCM.
Rajani P. Brandsen +6 more
wiley +1 more source
Intravitreal ranibizumab and bevacizumab in combination with full-fluence verteporfin therapy and dexamethasone for exudative age-related macular degeneration. [PDF]
, 2011 PURPOSE: To evaluate the efficacy and safety of triple therapy with intravitreal anti-vascular-endothelial-growth-factor (VEGF) antibody, dexamethasone and verteporfin photodynamic therapy (PDT) for exudative age-related macular degeneration (AMD ...
Adenis JP +4 more
core +1 more source